encainide

Phase 2Small molecule

NNational Heart, Lung, and Blood Institute (NHLBI)

encainide is one of 22 small molecule programs targeting Cardiac Arrhythmia. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Cardiac ArrhythmiaActive, not recruiting

Cardiac ArrhythmiaPhase 2

Active, not recruiting

Competition

Competitive Landscape

24 competitors in Cardiac Arrhythmia

#DrugCompanyPhaseTrials

Colcrys

Alnylam Pharmaceuticals

Klor-Con

Multaq

Tambocor

3 5

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Approved

1 6

Epsom Salt

FFresenius Kabi Oncology Ltd.

Approved

1 7

Cordarone

WWyeth-Lederle Vaccines

Approved

1 8

Pronestyl

Bristol-Myers Squibb

Approved

2 9

Quinidine Gluconate

WWyeth-Lederle Vaccines

Approved

—10

Ancef

BBaxter Healthcare Corporation

Approved

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Cardiac Arrhythmia2 trials

Cardiac Arrhythmia Suppression Trial (CAST)

Completed·NNational Heart, Lung, and Blood Institute (NHLBI)·Phase 3·NCT00000526

Cardiac Arrhythmia Pilot Study (CAPS)

Completed·NNational Heart, Lung, and Blood Institute (NHLBI)·Phase 2·NCT00000504

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for encainide. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — encainide compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for encainide. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — National Heart, Lung, and Blood Institute (NHLBI) company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: NNational Heart, Lung, and Blood Institute (NHLBI)

encainide

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Cardiac Arrhythmia2 trials

References

Drug Info

Quick Facts

Related News